Next Article in Journal
Efficiency of Utilizing Bulls with High Immune Response (HIR) in Terms of Reproductive Traits of PHF Cows
Previous Article in Journal
Biological Significance of the Komodo Dragon’s Tail (Varanus komodoensis, Varanidae)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Animals
Volume 14
Issue 15
10.3390/ani14152143
animals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Testosterone Inhibits Lipid Accumulation in Porcine Preadipocytes by Regulating ELOVL3

by
Fuyin Xie
1,
Yubei Wang
2,
Shuheng Chan
1,
Meili Zheng
3,
Mingming Xue
1,
Xiaoyang Yang
1,
Yabiao Luo
1,* and
Meiying Fang
1,2,*
1
Department of Animal Genetics and Breeding, National Engineering Laboratory for Animal Breeding, MOA Key Laboratory of Animal Genetics and Breeding, Beijing Key Laboratory for Animal Genetic Improvement, State Key Laboratory of Animal Biotech Breeding, Frontiers Science Center for Molecular Design Breeding, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China
2
Sanya Research Institute, China Agricultural University, Sanya 572025, China
3
Beijing General Station of Animal Husbandry, Beijing 100107, China
*
Authors to whom correspondence should be addressed.
Animals 2024, 14(15), 2143; https://doi.org/10.3390/ani14152143
Submission received: 26 June 2024 / Revised: 7 July 2024 / Accepted: 19 July 2024 / Published: 23 July 2024
(This article belongs to the Section Pigs)
Browse Figures
Versions Notes

Abstract

:

Simple Summary

Castration induces fat deposition in boars and decreases carcass quality, prompting extensive research on the regulatory mechanism of fat deposition in castrated boars from a genetic perspective. Consequently, this study aimed to conduct a series of molecular biological experiments to elucidate how testosterone inhibits lipid droplet accumulation in porcine preadipocytes through ELOVL3. The findings from this study offer crucial data supporting genetic analyses of porcine fat deposition due to castration, thereby significantly contributing to enhancing pork quality and improving pig production efficiency.

Abstract

Castration is commonly used to reduce stink during boar production. In porcine adipose tissue, castration reduces androgen levels resulting in metabolic disorders and excessive fat deposition. However, the underlying detailed mechanism remains unclear. In this study, we constructed porcine preadipocyte models with and without androgen by adding testosterone exogenously. The fluorescence intensity of lipid droplet (LD) staining and the fatty acid synthetase (FASN) mRNA levels were lower in the testosterone-treated cells than in the untreated control cells. In contrast, the mRNA levels of adipose triglycerides lipase (ATGL) and androgen receptor (AR) were higher than in the testosterone-treated cells than in the control cells. Subsequently, transcriptomic sequencing of porcine preadipocytes incubated with and without testosterone showed that the mRNA expression levels of very long-chain fatty acid elongase 3 (ELOVL3), a key enzyme involved in fatty acids synthesis and metabolism, were high in control cells. The siRNA-mediated knockdown of ELOVL3 reduced LD accumulation and the mRNA levels of FASN and increased the mRNA levels of ATGL. Next, we conducted dual-luciferase reporter assays using wild-type and mutant ELOVL3 promoter reporters, which showed that the ELOVL3 promoter contained an androgen response element (ARE); furthermore, its transcription was negatively regulated by AR overexpression. In conclusion, our study reveals that testosterone inhibits fat deposition in porcine preadipocytes by suppressing ELOVL3 expression. Moreover, our study provides a theoretical basis for further studies on the mechanisms of fat deposition caused by castration.

1. Introduction

Castration is used in pig production to remove taint. However, it leads to fat deposition and excessive fat tissue impacts meat quality and reduces pork production efficiency, ultimately leading to profit losses. We previously showed that the weight, backfat thickness, and abdominal fat weight of castrated pigs were significantly higher than those of intact pigs [1]. Currently, two types of castration are used: immune and surgical. Both aim to reduce testosterone release [2]. Pig castration causes a dramatic decrease in testosterone expression, which slows muscle growth and increases fat accumulation. This phenomenon is observed not only in pigs but also in other species. Several studies have demonstrated a negative correlation between obesity and the levels of free testosterone, bioavailable testosterone (free and albumin-bound), and total testosterone (free, bioavailable, and bound to sex-hormone-binding globulin [SHBG]), which is maintained in all age groups [3,4,5,6,7]. These data indicate a strong relationship between testosterone and fat deposition. However, the molecular mechanism underlying the association between testosterone and fat deposition in pigs remains unclear.
ELOVL3 is a family member of the elongases of very long-chain fatty acids (ELOVLs), and it is mainly expressed in the liver and adipose tissue and catalyzes the production of saturated and unsaturated long-chain fatty acids, such as C16, C18, and C20 [8,9,10,11]. The roles of ELOVL3 in the skin, adipose tissue, and the liver have been extensively studied [12,13,14,15,16]. ELOVL3-ablated mice showed impaired formation of triglycerides and LD in the skin and brown adipose tissue [15,16]. Activation of ELOVL3 expression is associated with increased fatty acid (FA) oxidation, and, during cold exposure, the enzyme functions in brown fat cells to replenish the intracellular pool of FAs and maintain lipid homeostasis [16]. ELOVL3 also directly regulates FA composition in subcutaneous white adipose tissue [17], and ELOVL3 expression and fat deposition are positively correlated. However, the association between ELOVL3 and testosterone remains unclear. Therefore, we aimed to explore the mechanism underlying obesity caused by testosterone deficiency and the relationship between ELOVL3 expression and fat deposition.
In the present study, we treated porcine preadipocytes with and without testosterone as cellular models of intact and castrated pigs and conducted a transcriptomic analysis of porcine preadipocytes incubated with and without testosterone to evaluate the role of ELOVL3 in the regulation of the castration-mediated fat deposition. Our findings provide a molecular basis for testosterone-mediated regulation of lipid metabolism.

2. Material and Methods

2.1. Cell Culture, Differentiation, and Testosterone Treatment

Porcine preadipocytes [18] were cultivated in growth medium (GM) consisting of DMEM/F12 supplemented with 10% fetal bovine serum (Gibco, New York, NY, USA) and 1% penicillin-streptomycin solution (Gibco) at 37 °C in a 5% CO2 humidified environment. We previously showed that 50 nM testosterone (Sigma, Ronkonkoma, NY, USA) significantly inhibited adipogenic differentiation of 3T3-L1 cells (Figure S1). Differentiation preadipocytes (at 100% confluence) was induced by incubating the cells in adipogenic medium (GM containing 0.25 mM 3-isobutyl-1-methylxanthine (Sigma), 1 µM dexamethasone (Sigma), and 5 mg/mL insulin (Sigma)) for 3 d with or without testosterone, followed by another 3 d incubating in fresh medium (GM containing 5 mg/mL insulin) with or without testosterone. In some experiments, cells were treated with 200 nM flutamide (Sigma) [19]. Every 3 d, the medium was replaced with fresh medium containing the same concentrations of testosterone or flutamide.

2.2. Oil Red O Staining

Oil Red O was used to stain adipocytes as previously described [20]. The cells were fixed with 4% paraformaldehyde (Solarbio, Beijing, China) for 20 min and rinsed twice with PBS (Gibco). The cells were then stained with Oil Red O solution for 20 min. Finally, the stained cells were examined under a microscope.

2.3. BODIPY 493/503 Staining

Living cells were incubated with 4% paraformaldehyde for 20 min and then stained with BODIPY staining (Beyotime Biotechnology, Shanghai, China) solution for 15 min at 37 °C in the dark. Next, the cells were washed with PBS and incubated with DAPI (Beyotime Biotechnology) for 10 min. Finally, the cells were analyzed under a fluorescence microscope.

2.4. Quantitative RT-PCR

Total RNA was extracted from cells using TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) and was reverse transcribed to obtain cDNA. The obtained cDNA was used as a template for qRT-PCR along with Taq Pro Universal SYBR qPCR Master Mix (Vazyme Biotech Co., Nanjing, China) and specific primers in a qTOWER 2.1 thermocycler (Analytikjene, Jena, Germany). The housekeeping gene β-actin was used as a control for normalization [21]. Primers for qRT-PCR were designed using the NCBI website and are listed in Table S1.

2.5. Transcriptomic Analysis of Porcine Preadipocytes Incubated with and without Testosterone

Cells were separately harvested on 6 d in the testosterone and control groups (n = 3 per group). Total RNA was extracted with TRIzol® reagent and then quantified and quality-checked using a Nanodrop. The mRNA library was built using 5 µg of RNA from six samples. The Illumina NovaSeq 6000 platform was used to build mRNA sequencing libraries. Sequenced data were quality-controlled, filtered, and mapped to the pig reference genome (Sus scrofa11.1) in HiSAT2. Gene expression was calculated in featureCounts and normalized to transcripts per million mapped reads (FPKM). The threshold for differentially expressed genes (DEGs) was set as adjusted p < 0.05 and |log2foldchange| > 1.

2.6. Small Interfering RNA Transfection

Three small interfering (si)RNAs targeting ELOVL3 were designed and synthesized commercially (GenePharma, Suzhou, China); their sequences are shown in Table S2. Cells were transfected with the siRNAs using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Briefly, preadipocytes were plated in 12-well plates and allowed to grow to 90% confluence. Cells were incubated for 30 min in Opti-MEM and transfected with siRNA (120 nM) using Lipofectamine 2000 reagent. A scrambled siRNA, also designed by GenePharma, was used as a negative control.

2.7. Plasmid Constructs, and Cell Transfection

The full-length cDNA (2690 bp) of AR (GenBank: NM_214314) was amplified by overlapping PCR using cDNA extracted from porcine ovarian granulosa cells as a template and was cloned into the pcDNA3.1-EGFP vector (YRgene, Changsha, China). The primers used for PCR amplification are listed in Table S3. We also co-transfected 293 T cells [21] with 500 ng of five different 5′ deletion constructs (−2000 bp/+100 bp, −1460 bp/+100 bp, −920 bp/+100 bp, and −380 bp/+100 bp, and −158 bp/+100 bp) or the pGL3-Basic vector (Promega, Beijing, China) and pRL-TK (Promega, Beijing, China) plasmid using Lipofectamine 2000 reagent for 48 h. Similarly, 293 T cells were co-transfected with pGL3-ELOVL3 wild-type or mutant plasmids and pcDNA3.1-AR or pcDNA3.1-EGFP vector for 48 h.

2.8. Cloning of the ELOVL3 Promoter Region and Bioinformatics Analysis

The porcine ELOVL3 5′-flanking sequence was amplified from porcine heart genomic DNA using 1.1 × S4 Fidelity PCR Mix (Genesand, Beijing, China). Primers used for PCR amplification are listed in Table S4 (−2000 to +100 bp; 2100 bp). The amplified product was cloned into the pGL3-Basic vector and sequenced (Sangon Biotech, Shanghai, China). Transcription factor binding sites in the ELOVL3 promoter were predicted using PROMO (https://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3 (accessed on 1 March 2023)) and the JARPAR database (https://jaspar.genereg.net/ (accessed on 1 March 2023)).

2.9. Deletion Analysis and Plasmid Construction

PCR primers were designed to hybridize at the −2000, −1460, −920, −380, and −158 bp positions to generate corresponding 5′ deletion derivatives using a common downstream primer at +100 bp (the 5′ deletion primers are listed in Table S4). The resulting amplicon was cloned into the pGL3-Basic vector using the KpnI/HindIII (NEB, Ipswich, MA, USA) sites. All plasmids were confirmed through DNA sequencing.

2.10. Site-Directed Mutagenesis

Overlap extension PCR was performed to generate site-directed mutants of the ELOVL3 promoter. Primers were designed to replace the predicted transcription factor binding sites with complementary sequences of ARE (the primer sequences are listed in Table S4). PCR generated two DNA fragments containing the designated mutations in the overlapping regions. Subsequently, the two DNA fragments were pooled as PCR templates to generate a full-length DNA fragment. The resulting amplicons were ligated into the pGL3-Basic vector into the KpnI and NheI-H (NEB) sites to create mutant constructs. Each mutant construct was confirmed through DNA sequencing.

2.11. Dual-Luciferase Reporter Assay

After 48 h incubation post-transfection, 293 T cells were harvested and lysed to measure luciferase activity. Relative luciferase activity was calculated as the ratio of firefly luciferase to renilla luciferase activity as determined using the Dual-Luciferase Reporter Assay System (Vazyme Biotech Co.) and a microplate reader, according to the manufacturer’s instructions.

2.12. Statistical Analysis

All treatments were conducted with three biological replicates. The significance of differences was assessed using a t-test and one-way ANOVA in SPSS software (version 26.0; SPSS Inc., Chicago, IL, USA). Data are presented as means ± SEM. Results of the t-test are denoted by asterisks: * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the control (on the bars) or between the indicated groups. Results of one-way ANOVA are indicated by letters. The absence of significant differences is indicated by identical letters (p > 0.05), while different lowercase letters denote significant differences (p < 0.05), and different capital letters signify highly significant differences (p < 0.01).

3. Result

3.1. Testosterone Treatment Inhibited Fat Accumulation and Altered the Expression of Lipid Metabolism-Related Genes

Oil Red O staining showed that testosterone inhibited the LD accumulation during adipogenic differentiation of porcine preadipocytes (Figure 1A,B). After incubation of porcine preadipocytes with testosterone for 6 d, FASN mRNA expression was down-regulated, and ATGL and AR mRNA expression was up-regulated (Figure 1C). Flutamide, a selective AR antagonist, markedly attenuated the inhibitory effects of testosterone on the adipogenic differentiation of porcine preadipocytes (Figure 1D,E).

3.2. Transcriptomic Profiles of Porcine Preadipocytes Incubated with Testosterone

To determine the molecular mechanism by which testosterone inhibits fat accumulation during adipogenic differentiation of porcine preadipocytes, we conducted transcriptomic sequencing of porcine preadipocytes treated with or without testosterone for 6 d. A comparison of the testosterone and control-treated cells identified 4425 DEGs (adjusted p < 0.05 and |log2FoldChange| > 1), including 1630 up-regulated genes and 2795 down-regulated genes (Figure 2A). To explore the functions of DEGs, we performed gene ontology (GO) and Kyoto Encyclopedia of Genes Genomes (KEGG) analyses. The results showed significant enrichment of GO terms related to cell proliferation, differentiation, and regulation of nucleic acid transcription, including RNA metabolism (positively regulated), RNA biosynthesis (positively regulated), and DNA template transcription (positively regulated), among other biological processes (Figure 2B). LDs are often observed adjacent to ER [22], and we observed a significant enrichment of GO entries related to cellular components associated with the ER as well (Figure 2B). The KEGG results showed that most DEGs were enriched in fat-related pathways, such as the wnt signal pathway, hedgehog signal pathway, and metabolic pathways (Figure 2C,D). Activation of wnt signaling and hedgehog signaling abolishes adipogenic differentiation by inhibiting the expression of adipogenic transcription factors [23]. Notably, the metabolic pathway possessed the most DEGs in the up-regulated differential gene KEGG enrichment analysis results, which was more than twice the number of genes in other enriched pathways. Further categorization of metabolic pathways showed that 18 up-regulated differential genes were significantly enriched in lipid metabolism pathways (Figure 2E). ELOVL3, a key gene involved in fatty acid synthesis and metabolism [16], was highly expressed in the control group (Tables S5 and S6). AKR1C1 plays an important role in female obesity due to its unique progesterone metabolic characteristics [24]. Research on PLA2G6 has predominantly focused on neurological diseases, and its relationship with androgen levels and fat deposition remains unexplored [25]. Consequently, we selected ELOVL3 as a candidate gene for further investigation.
Taken together, these results suggest that testosterone plays a crucial role in adipogenesis through interactions with the DEGs and signaling pathways associated with adipogenesis and metabolism.

3.3. Knockdown of ELOVL3 Expression Inhibited Porcine Fat Accumulation

First, we verified the regulation of ELOVL3 gene expression by testosterone. The ELOVL3 gene expression was significantly down-regulated after being treated with testosterone, and the down-regulation of ELOVL3 gene expression was rescued when treated with testosterone and flutamide (Figure 3A). Further, to explore the role of ELOVL3 in the adipogenic differentiation of porcine preadipocytes, we designed three ELOVL3 siRNAs (si-410-ELOVL3, si-713-ELOVL3, and si-394-ELOVL3) and determined their interference efficiency. The results showed that si-713-ELOVL3 exhibited the strongest inhibitory effect (Figure 3B) and was chosen for all subsequent experiments. Oil Red O staining results showed that porcine preadipocytes transfected with si-713-ELOVL3 accumulated significantly fewer LDs than the control group 6 days after the induction of differentiation (Figure 3C,D). Furthermore, qRT-PCR results showed that ATGL mRNA levels were significantly up-regulated in preadipocytes transfected with si-713-ELOVL3, whereas FASN mRNA levels were significantly down-regulated (Figure 3E). These results suggest that the knockdown of ELOVL3 expression inhibited the adipogenic differentiation of porcine preadipocytes.

3.4. AR Targets the ELOVL3 Promoter and Inhibits Its Transcriptional Activity

It is well known that gene expression levels are directly related to promoter transcriptional activity. Transcriptome sequencing analysis after testosterone treatment showed differential genes significantly enriched in transcriptional regulation-related GO items. Therefore, we analyzed the promoter transcriptional activity of ELOVL3. We conducted five promoter fragments (−2000 bp/+100 bp, −1460 bp/+100 bp, −920 bp/+100 bp, −380 bp/+100 bp, −158 bp/+100 bp) and cloned them into the pGL3-Basic vector. Dual-luciferase reporter gene assay showed that deletion of the ELOVL3 promoter (−2004 bp/−384 bp) significantly increased the promoter activity (p < 0.01), whereas the promoter activity decreased rapidly when the −384 bp/−158 bp region was deleted (p < 0.01; Figure 4A). This suggests that the −384 bp/−158 bp region is the essential promoter region of the ELOVL3 gene. Testosterone normally exerts its biological effects by binding to the AR [26]. To determine whether ELOVL3 is regulated by AR, the presence of ARE between −384 bp and −158 bp was predicted using PROMO and JARPAR databases. Moreover, 293 T cells were transiently co-transfected for 48 h with one of the two ELOVL3 promoter luciferase structures (wild-type or mutant structure, predicted to be variable) and together with a porcine AR overexpression vector (pcDNA3.1-AR) or an empty vector (pcDNA3.1-EGFP). Dual-luciferase reporter gene assays showed that AR overexpression significantly repressed the activity of the ELOVL3 promoter wild-type (p < 0.01) but not the mutant promoter (Figure 4B). This suggests that AR can regulate the transcriptional activity of the ELOVL3 promoter region by directly targeting it and modulating its transcriptional activity.

4. Discussion

Testosterone is the main androgen in mammals and is secreted by Leydig cells [27]. In addition to its involvement in the development of male reproductive organs, testosterone also plays several important roles in adipose tissue [28]. Adipose tissue has been identified as an endocrine organ that secretes adipokines involved in metabolic and inflammatory pathways. Testosterone can affect adipocyte proliferation and differentiation, thereby affecting body fat composition, adipocyte function, and lipid metabolism [18]. Castration eliminates endogenous sources of testosterone production in the body. An analysis of castrated and intact pigs showed that castrated pigs exhibit lower serum testosterone levels and higher fat accumulation compared to intact pigs [29]. Numerous clinical and animal experiments have also confirmed that low testosterone levels can lead to massive fat deposition in the body [18]. To investigate the molecular mechanism underlying castration-induced lipid deposition in pigs, we incubated porcine preadipocytes with testosterone to simulate the androgen status of intact pigs. Here, we present data that demonstrate that testosterone inhibited the LD accumulation in porcine adipocytes and altered the expression of lipid metabolism-related genes, like ATGL and FASN. LDs are storage organelles at the center of lipid and energy balance [30]. The size and abundance of LDs determine their capacity for lipid storage. ATGL encodes an enzyme that promotes lipolysis in adipocytes, and FASN encodes a key enzyme involved in the de novo synthesis of fatty acids [31,32]. Lipid metabolism comprises two distinct processes: fatty acid β-oxidation and lipid synthesis [33]. FASN and ATGL are involved in these processes. Fat deposition results from an imbalance between lipid synthesis and lipolysis. These data indicate that testosterone regulates lipid metabolism to inhibit porcine subcutaneous fat deposition.
We conducted the transcriptomic sequencing of porcine preadipocytes incubated with and without testosterone for 6 d. Transcriptome data suggest that ELOVL3 is a positive regulator of lipid accumulation in porcine preadipocytes. Rolf et al.’s data show that the elongase ELOVL3 does affect the condensation reaction, which is the rate-limiting step for the elongation cycle of VLCFAs [15]. VLCFAs are important constituents of glycerophospholipids, sphingolipids, triglycerides, and sterol- and wax-esters [34]. Blocking ELOVL3 expression with siRNA inhibited the expression of FASN and the LD formation and accumulation. Consistent with these findings, Zadravec et al. showed that ELOVL3 knockout mice have reduced adiponectin levels, limited adipose tissue expansion, and resistance to diet-induced obesity [34].
Testosterone often exerts its effects through a classical pathway, in which testosterone binds to cytosolic AR, a ligand-activated transcription factor. Once activated, AR translocate into the nucleus to bind to AREs located in or near the promoter region of the target gene, thereby influencing its expression [35]. The expression of AR in pigs is tissue-specific, with high expression primarily observed in many endocrine glands, followed by adipose tissues, and relatively low expression in muscle and immunologic tissues [29]. AR plays an important role in the mechanisms of testosterone action in adipose tissue. Specific fat tissue AR knockdown (fARKO) mice developed metabolic dysregulation on a normal diet with early insulin resistance and hyperinsulinemia [36]. In our study, we observed that testosterone upregulated the expression of AR, consistent with findings reported by Liu in adipose tissue of control and castrated pigs [29]. Previous studies have demonstrated that the testosterone dose-dependent inhibition of lipogenic differentiation in 3T3-L1 cells could be partially blocked by flutamide, a selective AR inhibitor [19]. As a specific androgen antagonist, flutamide competitively inhibits androgen receptors and performs a direct blockage of androgenic effect [37]. In the present study, flutamide was found to ameliorate the inhibitory effect of testosterone on the LD accumulation in porcine preadipocytes, which suggested the involvement of AR signaling in androgen inhibition of porcine preadipocyte fat accumulation.
Transcriptome data suggest that testosterone deficiency contributes to the presence of ELOVL3 in obesity. Our study involved an analysis of the activity within the promoter region of the ELOVL3 gene, coupled with ARE prediction, revealing the presence of an ARE in the −384 to −158 region. Testosterone treatment led to an increase in the expression of AR while decreasing the expression of ELOVL3. The opposing effects observed on AR and ELOVL3 expression suggest a potential negative regulatory role of AR on ELOVL3. Thus, we performed luciferase assays using a reporter vector, driven by the ELOVL3 promoter, containing the wild-type AREs or mutated AREs. A dual-luciferase reporter assay showed that the overexpression of AR had no significant impact on the activity of the ELOVL3 promoter when the predicted ARE was altered, indicating that the inhibitory effect of AR was abolished. These results indicated that AR inhibited activation of the ELOVL3 promoter, and this down-regulation may require binding through the ARE in the ELOVL3 promoter region. In conclusion, our findings support the hypothesis that testosterone may bind AR to suppress the expression level of ELOVL3.
Some limitations in our study, namely, the functional differences between porcine preadipocytes cultured in vitro and porcine preadipocytes grown in vivo, should be taken into account. Given the complexity of an organism’s environment, it is hard to fully mimic the characteristics of castration in vitro. In the current study, testosterone may affect the expression level of FASN and ATGL via AR by targeting ELOVL3 and suppressing porcine fat deposition. The findings from this study enhance our comprehension of the mechanism behind increased fat deposition resulting from testosterone deficiency. Taken together, our in vitro porcine culture system provided a new possibility for establishing the in vitro model of fat accumulation in castrated boars; however, more evidence is needed to confirm this in vitro model.

5. Conclusions

This study suggests that testosterone regulates ELOVL3 to influence lipid metabolism and inhibit lipid droplet accumulation in porcine preadipocytes, potentially via the AR signaling pathway (Figure 5). However, further validation is needed to elucidate the precise molecular mechanism of ELOVL3 in fat deposition in castrated boars. This research contributes to our understanding of how ELOVL3 functions in fat deposition following testosterone depletion, providing both theoretical insights and empirical evidence for comprehending the molecular mechanisms underlying fat deposition due to castration in pigs.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ani14152143/s1, Table S1: Characteristics of primers used in the qRT-PCR reaction; Table S2: ELOVL3 small interfering RNA (siRNA) oligonucleotide sequences; Table S3: Primers used for constructing AR overexpression plasmid; Table S4: Primers used for cloning, deletion, and site-directed mutagenesis of ELOVL3; Table S5: Summary of 18 lipid metabolism-related genes identified through KEGG analysis; Table S6: KEGG analysis of ELOVL3; Figure S1: Effect of testosterone on adipogenic differentiation of 3T3-L1 cells.

Author Contributions

M.F. and F.X. were responsible for the study concept and design. F.X. conducted the experiments. Y.W. was responsible for transcriptome data analysis. F.X., M.Z. and X.Y. analyzed the data. M.F. and F.X. drafted the manuscript. S.C., M.X. and Y.L. reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (U22A20508) and the National Key Research and Development Program of China (2023YFF1001001&2022YFF1003401) and the China Agriculture Research System of MOF and MARA (CARS-36).

Institutional Review Board Statement

This study was approved by the Laboratory Animal Welfare and Animal Experimental Ethical Inspection Committee of China Agricultural University with permission number AW32202202-2-1.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Liu, X.; Bai, Y.; Cui, R.; He, S.; Zhao, X.; Wu, K.; Fang, M. Sus_circPAPPA2 Regulates Fat Deposition in Castrated Pigs through the miR-2366/GK Pathway. Biomolecules 2022, 12, 753. [Google Scholar] [CrossRef]
  2. Li, H.; Gariépy, C.; Jin, Y.; Font, I.F.M.; Fortin, J.; Rocha, L.M.; Faucitano, L. Effects of ractopamine administration and castration method on muscle fiber characteristics and sensory quality of the longissimus muscle in two Piétrain pig genotypes. Meat Sci. 2015, 102, 27–34. [Google Scholar] [CrossRef]
  3. Allen, N.E.; Appleby, P.N.; Davey, G.K.; Key, T.J. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 2002, 13, 353–363. [Google Scholar] [CrossRef]
  4. Gapstur, S.M.; Gann, P.H.; Kopp, P.; Colangelo, L.; Longcope, C.; Liu, K. Serum androgen concentrations in young men: A longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol. Biomark. Prev. 2002, 11, 1041–1047. [Google Scholar]
  5. Jensen, T.K.; Andersson, A.M.; Jørgensen, N.; Andersen, A.G.; Carlsen, E.; Petersen, J.H.; Skakkebaek, N.E. Body mass index in relation to semen quality and reproductive hormones among 1558 Danish men. Fertil. Steril. 2004, 82, 863–870. [Google Scholar] [CrossRef]
  6. Svartberg, J.; von Mühlen, D.; Schirmer, H.; Barrett-Connor, E.; Sundfjord, J.; Jorde, R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur. J. Endocrinol. 2004, 150, 65–71. [Google Scholar] [CrossRef]
  7. Svartberg, J.; von Mühlen, D.; Sundsfjord, J.; Jorde, R. Waist circumference and testosterone levels in community dwelling men. The Tromsø study. Eur. J. Epidemiol. 2004, 19, 657–663. [Google Scholar] [CrossRef]
  8. Bryzgalova, G.; Gao, H.; Ahren, B.; Zierath, J.R.; Galuska, D.; Steiler, T.L.; Dahlman-Wright, K.; Nilsson, S.; Gustafsson, J.A.; Efendic, S.; et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: Insulin sensitivity in the liver. Diabetologia 2006, 49, 588–597. [Google Scholar] [CrossRef]
  9. Denic, V.; Weissman, J.S. A molecular caliper mechanism for determining very long-chain fatty acid length. Cell 2007, 130, 663–677. [Google Scholar] [CrossRef]
  10. Jakobsson, A.; Westerberg, R.; Jacobsson, A. Fatty acid elongases in mammals: Their regulation and roles in metabolism. Prog. Lipid Res. 2006, 45, 237–249. [Google Scholar] [CrossRef]
  11. Tvrdik, P.; Asadi, A.; Kozak, L.P.; Nedergaard, J.; Cannon, B.; Jacobsson, A. Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue. J. Biol. Chem. 1997, 272, 31738–31746. [Google Scholar] [CrossRef]
  12. Anzulovich, A.; Mir, A.; Brewer, M.; Ferreyra, G.; Vinson, C.; Baler, R. Elovl3: A model gene to dissect homeostatic links between the circadian clock and nutritional status. J. Lipid Res. 2006, 47, 2690–2700. [Google Scholar] [CrossRef]
  13. Brolinson, A.; Fourcade, S.; Jakobsson, A.; Pujol, A.; Jacobsson, A. Steroid hormones control circadian Elovl3 expression in mouse liver. Endocrinology 2008, 149, 3158–3166. [Google Scholar] [CrossRef]
  14. Gudjonsson, J.E.; Ding, J.; Johnston, A.; Tejasvi, T.; Guzman, A.M.; Nair, R.P.; Voorhees, J.J.; Abecasis, G.R.; Elder, J.T. Assessment of the psoriatic transcriptome in a large sample: Additional regulated genes and comparisons with in vitro models. J. Investig. Dermatol. 2010, 130, 1829–1840. [Google Scholar] [CrossRef]
  15. Westerberg, R.; Månsson, J.E.; Golozoubova, V.; Shabalina, I.G.; Backlund, E.C.; Tvrdik, P.; Retterstøl, K.; Capecchi, M.R.; Jacobsson, A. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J. Biol. Chem. 2006, 281, 4958–4968. [Google Scholar] [CrossRef]
  16. Westerberg, R.; Tvrdik, P.; Undén, A.B.; Månsson, J.E.; Norlén, L.; Jakobsson, A.; Holleran, W.H.; Elias, P.M.; Asadi, A.; Flodby, P.; et al. Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J. Biol. Chem. 2004, 279, 5621–5629. [Google Scholar] [CrossRef]
  17. Ji, L.; Gupta, M.; Feldman, B.J. Vitamin D Regulates Fatty Acid Composition in Subcutaneous Adipose Tissue Through Elovl3. Endocrinology 2016, 157, 91–97. [Google Scholar] [CrossRef]
  18. Liu, X.; Bai, Y.; Cui, R.; He, S.; Ling, Y.; Wu, C.; Fang, M. Integrated Analysis of the ceRNA Network and M-7474 Function in Testosterone-Mediated Fat Deposition in Pigs. Genes 2022, 13, 668. [Google Scholar] [CrossRef]
  19. Singh, R.; Artaza, J.N.; Taylor, W.E.; Braga, M.; Yuan, X.; Gonzalez-Cadavid, N.F.; Bhasin, S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006, 147, 141–154. [Google Scholar] [CrossRef]
  20. Zhong, X.J.; Shen, X.D.; Wen, J.B.; Kong, Y.; Chu, J.J.; Yan, G.Q.; Li, T.; Liu, D.; Wu, M.Q.; Zeng, G.H.; et al. Osteopontin-induced brown adipogenesis from white preadipocytes through a PI3K-AKT dependent signaling. Biochem. Biophys. Res. Commun. 2015, 459, 553–559. [Google Scholar] [CrossRef]
  21. Xiao, L.; Xu, Q.; Liu, X.; Chan, S.; Luo, Y.; He, S.; Fang, M. The Novel-miR-659/SPP1 Interaction Regulates Fat Deposition in Castrated Male Pigs. Animals 2022, 12, 944. [Google Scholar] [CrossRef]
  22. Ohsaki, Y.; Sołtysik, K.; Fujimoto, T. The Lipid Droplet and the Endoplasmic Reticulum. Adv. Exp. Med. Biol. 2017, 997, 111–120. [Google Scholar] [CrossRef]
  23. Moseti, D.; Regassa, A.; Kim, W.K. Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules. Int. J. Mol. Sci. 2016, 17, 124. [Google Scholar] [CrossRef]
  24. Chu, X.; He, S.; Liu, Y.; Liu, Y.; Feng, F.; Guo, Q.; Zhao, L.; Sun, H. Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors. Chem. Biol. Interact. 2022, 351, 109746. [Google Scholar] [CrossRef]
  25. Morgan, N.V.; Westaway, S.K.; Morton, J.E.; Gregory, A.; Gissen, P.; Sonek, S.; Cangul, H.; Coryell, J.; Canham, N.; Nardocci, N.; et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 2006, 38, 752–754. [Google Scholar] [CrossRef]
  26. Ketchem, J.M.; Bowman, E.J.; Isales, C.M. Male sex hormones, aging, and inflammation. Biogerontology 2023, 24, 1–25. [Google Scholar] [CrossRef]
  27. Tostes, R.C.; Carneiro, F.S.; Carvalho, M.H.; Reckelhoff, J.F. Reactive oxygen species: Players in the cardiovascular effects of testosterone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 310, R1–R14. [Google Scholar] [CrossRef]
  28. Gooren, L.J. Androgens and male aging: Current evidence of safety and efficacy. Asian J. Androl. 2010, 12, 136–151. [Google Scholar] [CrossRef]
  29. Liu, C.; Ma, J.; Zhang, J.; Zhao, H.; Zhu, Y.; Qi, J.; Liu, L.; Zhu, L.; Jiang, Y.; Tang, G.; et al. Testosterone Deficiency Caused by Castration Modulates Mitochondrial Biogenesis Through the AR/PGC1α/TFAM Pathway. Front. Genet. 2019, 10, 505. [Google Scholar] [CrossRef]
  30. Olzmann, J.A.; Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 2019, 20, 137–155. [Google Scholar] [CrossRef] [PubMed]
  31. Gandhi, A.Y.; Yu, J.; Gupta, A.; Guo, T.; Iyengar, P.; Infante, R.E. Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia. Front. Oncol. 2022, 12, 841758. [Google Scholar] [CrossRef]
  32. Zhang, J.; Song, Y.; Shi, Q.; Fu, L. Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis. Front. Med. 2021, 15, 649–656. [Google Scholar] [CrossRef]
  33. Shen, H.H.; Zhao, Q.; Wen, Y.P.; Wu, R.; Du, S.Y.; Huang, X.B.; Wen, X.T.; Cao, S.J.; Zeng, L.; Yan, Q.G. Porcine reproductive and respiratory syndrome virus upregulates SMPDL3B to promote viral replication by modulating lipid metabolism. iScience 2023, 26, 107450. [Google Scholar] [CrossRef]
  34. Zadravec, D.; Brolinson, A.; Fisher, R.M.; Carneheim, C.; Csikasz, R.I.; Bertrand-Michel, J.; Borén, J.; Guillou, H.; Rudling, M.; Jacobsson, A. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J. 2010, 24, 4366–4377. [Google Scholar] [CrossRef]
  35. Shihan, M.; Bulldan, A.; Scheiner-Bobis, G. Non-classical testosterone signaling is mediated by a G-protein-coupled receptor interacting with Gnα11. Biochim. Biophys. Acta 2014, 1843, 1172–1181. [Google Scholar] [CrossRef]
  36. Anderson, L.A.; McTernan, P.G.; Barnett, A.H.; Kumar, S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: Influence of gender and site. J. Clin. Endocrinol. Metab. 2001, 86, 5045–5051. [Google Scholar] [CrossRef]
  37. Liao, B.; Qi, X.; Yun, C.; Qiao, J.; Pang, Y. Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. Front. Endocrinol. 2022, 13, 815968. [Google Scholar] [CrossRef] [PubMed]
Animals 14 02143 g001
Figure 1. Testosterone treatment inhibited fat accumulation and altered the expression of lipid metabolism-related genes: (A) Oil Red O was used to stain porcine preadipocytes on the 6 d in the testosterone (T) and control groups (bar = 100 μm). (B) Quantification of LDs using Oil Red O analysis on the 6 d in the testosterone (T) and control groups. (C) The levels of FASN, ATGL, and AR mRNA in T group and control group on the 6 d of adipogenic differentiation of porcine preadipocytes were analyzed using quantitative RT-PCR. (D) LDs stained with BODIPY 493/503 in the T, testosterone + flutamide (T + F), and control groups (bar = 130 μm); (E) Quantitative RT-PCR analysis of the mRNA levels of FASN, ATGL, and AR on the 6 d in the T, T + F, and control groups. n = 3 per group. Statistical comparisons were performed with a t-test with one-way ANOVA. All data are expressed as means ± SEM. Results of the t-test are denoted by asterisks: * p < 0.05, *** p < 0.001 compared to the control (on the bars) or between the indicated groups. Results of one-way ANOVA are indicated by letters. The absence of significant differences is indicated by identical letters (p > 0.05), while different lowercase letters denote significant differences (p < 0.05), and different capital letters signify highly significant differences (p < 0.01).
Figure 1. Testosterone treatment inhibited fat accumulation and altered the expression of lipid metabolism-related genes: (A) Oil Red O was used to stain porcine preadipocytes on the 6 d in the testosterone (T) and control groups (bar = 100 μm). (B) Quantification of LDs using Oil Red O analysis on the 6 d in the testosterone (T) and control groups. (C) The levels of FASN, ATGL, and AR mRNA in T group and control group on the 6 d of adipogenic differentiation of porcine preadipocytes were analyzed using quantitative RT-PCR. (D) LDs stained with BODIPY 493/503 in the T, testosterone + flutamide (T + F), and control groups (bar = 130 μm); (E) Quantitative RT-PCR analysis of the mRNA levels of FASN, ATGL, and AR on the 6 d in the T, T + F, and control groups. n = 3 per group. Statistical comparisons were performed with a t-test with one-way ANOVA. All data are expressed as means ± SEM. Results of the t-test are denoted by asterisks: * p < 0.05, *** p < 0.001 compared to the control (on the bars) or between the indicated groups. Results of one-way ANOVA are indicated by letters. The absence of significant differences is indicated by identical letters (p > 0.05), while different lowercase letters denote significant differences (p < 0.05), and different capital letters signify highly significant differences (p < 0.01).
Animals 14 02143 g001
Animals 14 02143 g002
Figure 2. Transcriptomic profiles of porcine preadipocytes incubated with testosterone: (A) Volcano plot of the statistically significant DEGs (adjusted p < 0.05 and |log2FoldChange| > 1) between the testosterone-treated and control preadipocytes. (B) GO analysis of the DEGs. (C) KEGG analysis of the down-regulated DEGs; (D) KEGG analysis of the up-regulated DEGs; (E) KEGG analysis of metabolism-related DEGs. n = 3 per group.
Figure 2. Transcriptomic profiles of porcine preadipocytes incubated with testosterone: (A) Volcano plot of the statistically significant DEGs (adjusted p < 0.05 and |log2FoldChange| > 1) between the testosterone-treated and control preadipocytes. (B) GO analysis of the DEGs. (C) KEGG analysis of the down-regulated DEGs; (D) KEGG analysis of the up-regulated DEGs; (E) KEGG analysis of metabolism-related DEGs. n = 3 per group.
Animals 14 02143 g002
Animals 14 02143 g003
Figure 3. Knockdown of ELOVL3 expression inhibited porcine fat accumulation: (A) ELOVL3 mRNA levels in the different groups were tested with qRT-PCR. (B) Porcine preadipocytes were transfected with ELOVL3 siRNAs (si-713-ELOVL3, si-394-ELOVL3, and si-410-ELOVL3) or a negative control siRNA, and ELOVL3 expression interference efficiency was analyzed at 48 h after transfection. The relative expression of ELOVL3 was normalized, and the relative values were expressed as the fold of induction relative to the negative control. (C) LD accumulation in preadipocytes transfected with either si-713-ELOVL3 or a negative control siRNA was analyzed using Oil Red O staining at 6 d of induction (bar = 100 μm). (D) Quantification of LDs using Oil Red O analysis on the 6 d in the si-713-ELOVL3 and negative control groups. (E) The mRNA levels of ELOVL3, FASN, and ATGL in the si-713-ELOVL3 and negative control group were confirmed as measured using qRT-PCR. n = 3 per group. All data are expressed as means ± SEM. Results of the t-test are denoted by asterisks: * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the control (on the bars) or between the indicated groups. Results of one-way ANOVA are indicated by letters. The absence of significant differences is indicated by identical letters (p > 0.05), while different lowercase letters denote significant differences (p < 0.05), and different capital letters signify highly significant differences (p < 0.01).
Figure 3. Knockdown of ELOVL3 expression inhibited porcine fat accumulation: (A) ELOVL3 mRNA levels in the different groups were tested with qRT-PCR. (B) Porcine preadipocytes were transfected with ELOVL3 siRNAs (si-713-ELOVL3, si-394-ELOVL3, and si-410-ELOVL3) or a negative control siRNA, and ELOVL3 expression interference efficiency was analyzed at 48 h after transfection. The relative expression of ELOVL3 was normalized, and the relative values were expressed as the fold of induction relative to the negative control. (C) LD accumulation in preadipocytes transfected with either si-713-ELOVL3 or a negative control siRNA was analyzed using Oil Red O staining at 6 d of induction (bar = 100 μm). (D) Quantification of LDs using Oil Red O analysis on the 6 d in the si-713-ELOVL3 and negative control groups. (E) The mRNA levels of ELOVL3, FASN, and ATGL in the si-713-ELOVL3 and negative control group were confirmed as measured using qRT-PCR. n = 3 per group. All data are expressed as means ± SEM. Results of the t-test are denoted by asterisks: * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the control (on the bars) or between the indicated groups. Results of one-way ANOVA are indicated by letters. The absence of significant differences is indicated by identical letters (p > 0.05), while different lowercase letters denote significant differences (p < 0.05), and different capital letters signify highly significant differences (p < 0.01).
Animals 14 02143 g003
Animals 14 02143 g004
Figure 4. AR targets the ELOVL3 promoter and inhibits its transcriptional activity: (A) Relative luciferase activity (Firefly: Renilla) at 48 h after transfection with different 5′ deletion ELOVL3 promoter constructs (−2000 bp/+100 bp, −1460 bp/+100 bp, −920 bp/+100 bp, −380 bp/+100 bp, −158 bp/+100 bp). (B) Effects of AR overexpression on wild-type and mutant ELOVL3 promoter activity. n = 3 per group. The luciferase activity was normalized, and the relative values were expressed as the fold of induction relative to the pcDNA3.1-EGFP vector activity. A one-way ANOVA test was used to assess the differences in luciferase activity. The absence of significant differences is denoted by the same letters (p > 0.05), while distinct lowercase letters indicate a significant difference (p < 0.05), and distinct capital letters signify a significant difference (p < 0.01).
Figure 4. AR targets the ELOVL3 promoter and inhibits its transcriptional activity: (A) Relative luciferase activity (Firefly: Renilla) at 48 h after transfection with different 5′ deletion ELOVL3 promoter constructs (−2000 bp/+100 bp, −1460 bp/+100 bp, −920 bp/+100 bp, −380 bp/+100 bp, −158 bp/+100 bp). (B) Effects of AR overexpression on wild-type and mutant ELOVL3 promoter activity. n = 3 per group. The luciferase activity was normalized, and the relative values were expressed as the fold of induction relative to the pcDNA3.1-EGFP vector activity. A one-way ANOVA test was used to assess the differences in luciferase activity. The absence of significant differences is denoted by the same letters (p > 0.05), while distinct lowercase letters indicate a significant difference (p < 0.05), and distinct capital letters signify a significant difference (p < 0.01).
Animals 14 02143 g004
Animals 14 02143 g005
Figure 5. Testosterone inhibits lipid accumulation in porcine preadipocytes by regulating ELOVL3.
Figure 5. Testosterone inhibits lipid accumulation in porcine preadipocytes by regulating ELOVL3.
Animals 14 02143 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Xie, F.; Wang, Y.; Chan, S.; Zheng, M.; Xue, M.; Yang, X.; Luo, Y.; Fang, M. Testosterone Inhibits Lipid Accumulation in Porcine Preadipocytes by Regulating ELOVL3. Animals 2024, 14, 2143. https://doi.org/10.3390/ani14152143

AMA Style

Xie F, Wang Y, Chan S, Zheng M, Xue M, Yang X, Luo Y, Fang M. Testosterone Inhibits Lipid Accumulation in Porcine Preadipocytes by Regulating ELOVL3. Animals. 2024; 14(15):2143. https://doi.org/10.3390/ani14152143

Chicago/Turabian Style

Xie, Fuyin, Yubei Wang, Shuheng Chan, Meili Zheng, Mingming Xue, Xiaoyang Yang, Yabiao Luo, and Meiying Fang. 2024. "Testosterone Inhibits Lipid Accumulation in Porcine Preadipocytes by Regulating ELOVL3" Animals 14, no. 15: 2143. https://doi.org/10.3390/ani14152143

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop